Pristiq and Breastfeeding
Clinical studies on Pristiq and breastfeeding have shown that the drug passes through breast milk in women. But it is not clear if the medication would cause any problems in a nursing child. Before taking Pristiq, breastfeeding women should talk to their healthcare providers about any potential risks. Such women should only take Pristiq if the benefits outweigh the expected risks.
Pristiq® (desvenlafaxine succinate) passes through breast milk in humans. If you are breastfeeding or are thinking about breastfeeding, talk with your healthcare provider before taking Pristiq. The manufacturer warns that the medication should be used in breastfeeding women only if the potential benefits outweigh the expected risks.
Studies have shown that Pristiq passes through breast milk in women. However, it is not clear if Pristiq could cause any negative effects in the nursing infant. Based on information with venlafaxine (Effexor®, Effexor® XR), a closely related medication, it is possible that Pristiq might cause slow weight gain. If you are taking Pristiq while breastfeeding, be sure to watch for possible side effects in your child.
Talking With Your Healthcare Provider About Pristiq and BreastfeedingYou should talk with your healthcare provider about Pristiq and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Pristiq and breastfeeding that is right for you.